Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Lc-Tab 6 X Tablet is a Health Canada–registered human drug (DIN 02132303) held by Standard Homeopathic International Co, containing Ledum Palustre. Health Canada lists its status as Cancelled Post Market (status date 24 Jul 2006). Nexara Health has matched 17 registrations of Ledum Palustre across 3 other regulated markets, 1 of them in the same strength and dosage form.

Health Canada registration

DIN02132303
Brand nameLc-Tab
Active ingredientLedum Palustre
Strength6 X
Dosage formTablet
RouteOral
CompanyStandard Homeopathic International Co
StatusCancelled Post Market — 24 Jul 2006
ClassHuman
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Ledum Palustre registered in other markets

17 registrations of the same molecule in 3 national registries outside Canada (first 13 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
NetherlandsLedum palustreVSM Geneesmiddelen B.V.TabletUitsluitend apotheek of drogistEU national register
NetherlandsLedum palustreBOIRON (Messimy)4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LMGlobuliUitsluitend apotheek of drogistEU national register
NetherlandsLedum palustreVSM Geneesmiddelen B.V.Druppels voor oraal gebruik, oplossingUitsluitend apotheek of drogistEU national register
NetherlandsLedum palustreBOIRON (Messimy)4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LMUitsluitend apotheek of drogistEU national register
United Arab EmiratesLedum Palustre - BoironBOIRON, France, MessimyMT to 200 CHPillulesActiveEDE
United StatesLedum PalustreHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesLedum PalustreHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesLedum PalustreHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesLedum PalustreHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesLedum PalustreHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesLedum PalustreHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesLedum PalustreHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesLedum PalustreHahnemann Laboratories, INC.PelletlistedFDA NDC

See every manufacturer of Ledum Palustre worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Lc-Tab (DIN 02132303) marketed in Canada?

No. Health Canada lists DIN 02132303 as Cancelled Post Market as of 24 Jul 2006.

Who holds the Canadian licence for this product?

Standard Homeopathic International Co is the company of record in the Health Canada Drug Product Database.

Is Ledum Palustre registered outside Canada?

Yes — Nexara Health has matched 17 registrations in 3 other markets, including 1 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02132303, status date 2006-07-24; national medicine registries: EDE, EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02132303, status date 2006-07-24; national medicine registries: EDE, EU national register, FDA NDC.

Health Canada Drug Product Database (DPD), DIN 02132303, status date 2006-07-24; national medicine registries: EDE, EU national register, FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.